FENC Fennec Pharmaceuticals

• None no insider bought on the open market
• $9.9M sold by 2 insiders outside a trading plan
• $1.4M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Marco Maria Brughera Director
   Planned sale
   $160K 15,545 shares at $10.29 100% of stake
   Traded Sep 15 Filed Sep 16
   ↗
3. Rosty Raykov Insider
   Planned sale
   $121K 10,000 shares at $12.11 7.4% of stake
   Traded Sep 1 Filed Sep 1
   ↗
4. Pierre Sargis Sayad Chief Medical Officer
   Sale
   $146K 12,000 shares at $12.18 56% of stake
   Traded Aug 31 Filed Aug 31
   ↗
5. Robert Andrade CFO
   Planned sale
   $884K 75,000 shares at $11.78 26% of stake
   Traded Aug 27 Filed Aug 28
   ↗
6. Rosty Raykov Insider
   Planned sale
   $96K 10,000 shares at $9.58 7.1% of stake
   Traded Aug 3 Filed Aug 4
   ↗
7. Southpoint Capital Advisors LP 10% owner, +4 joint filers
   Sale
   $7.5M 1,000,000 shares at $7.50 27% of stake
   Traded Dec 24, 2025 Filed Dec 29, 2025
   ↗
8. Rosty Raykov Director
   Planned sale
   $75K 10,000 shares at $7.54 11% of stake
   Traded Dec 5, 2025 Filed Dec 5, 2025
   ↗
9. Southpoint Capital Advisors LP 10% owner, +4 joint filers
   Sale
   $170K 19,341 shares at $8.79 0.5% of stake
   Traded Nov 18, 2025 Filed Nov 20, 2025
   ↗
10. Southpoint Capital Advisors LP 10% owner, +4 joint filers
    Sale
    $2M 246,018 shares at $8.27 6.1% of stake
    Traded Nov 14–17 Filed Nov 17, 2025
    ↗
11. Rosty Raykov Director
    Planned sale
    $81K 10,000 shares at $8.10 11% of stake
    Traded Nov 5, 2025 Filed Nov 6, 2025
    ↗
12. Southpoint Capital Advisors LP 10% owner, +4 joint filers
    Sale
    $636K 67,114 shares at $9.48 1.6% of stake
    Traded Oct 7–9 Filed Oct 9, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 45 stock grants, 39 option exercises, and 8 sales to cover taxes.